Dismiss Modal
Lee M. Hilliard, MD

Lee M. Hilliard, MD

Pediatric Hematology Oncology

Office Locations

Professor of Pediatrics


  • Residency: Arkansas Children’s Hospital
  • Medical School: University of Mississippi School of Medicine
  • Internship: Arkansas Children’s Hospital

Board Certifications

  • American Board of Pediatrics: Pediatrics (1993)
  • American Board of Pediatrics - Hematology-Oncology (1996)

Honors and Awards

ASH Advocacy Leadership Institute, Central Alabama Sickle Cell Foundation Provider Award

Special Interests

Dr. Hilliard is the Associate Professor of Pediatrics. Her area of focus is hematology. Specifically, her interests include clinical care and research in sickle cell disease. Dr. Hilliard focuses on stroke risk assessment and prevention, health care delivery in rural areas, management of iron overload in chronically transfused patients (including the use of erythrocytapheresis) and the use of hydroxyurea in sickle cell disease.


Sickle cell disease and other blood disorders, health care advocacy

Professional Organizations

American Society of Hematology(ASH), American Society of Pediatric Hematology/Oncology


1. Hilliard L, Maddox M, Tang S, Phd, Howard T. Development of a Regionalized, Comprehensive Care Network for Pediatric Sickle Cell Disease Improves Access to Care in a Rural State. J Disease Manage Health Outcomes 2004;12: 393-98 2. Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia.Lebensburger JD, Patel RJ, Palabindela P, Bemrich-Stolz CJ, Howard TH, Hilliard LM. J Blood Med. 2015 Dec 15;6:285-90. doi: 10.2147/JBM.S97405 3. Li, G and Hilliard LM. Morphologic features of normoblasts in a case of myopathy, lactic acidosis, and sideroblastic anemia. Blood 2017 Feb 23:1057. PMID: 28232625